QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa)
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative proctitis
- Focus Therapeutic Use
- Acronyms QUARTZ
- Sponsors Ferring Pharmaceuticals
- 06 Mar 2018 Planned End Date changed from 1 Feb 2018 to 31 Mar 2018.
- 28 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 04 Jan 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.